Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME

Summary

To explore a more clinical feasible treatment regime with ranibizumab for DME to provide satisfactory treatment effect with a lower number of visits and injections.

Timeline

Start

2014-12-12

Primary completion

2017-09-12

Completion

2017-09-12

Drugs

Indications